- Home
- COOK vs KZIA Comparison
COOK vs KZIA Comparison
Compare COOK & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COOK | KZIA |
|---|---|---|
| Founded | 1985 | 1994 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.4M | 154.5M |
| IPO Year | 2021 | 2002 |
Fundamental Metrics
Financial Performance| Metric | COOK | KZIA |
|---|---|---|
| Price | $54.45 | $13.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $53.00 | $19.50 |
| AVG Volume (30 Days) | 55.0K | ★ 207.4K |
| Earning Date | 05-11-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $559,520,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.07 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $4.86 |
| 52 Week High | $86.59 | $17.40 |
Technical Indicators
Market Signals| Indicator | COOK | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 35.54 | 54.77 |
| Support Level | $39.02 | $11.39 |
| Resistance Level | $76.22 | $14.75 |
| Average True Range (ATR) | 4.04 | 1.01 |
| MACD | -0.80 | 0.13 |
| Stochastic Oscillator | 5.19 | 66.91 |
Price Performance
Historical ComparisonAbout COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.